TrademarkDir
ONCOREVEAL
LIVE

Serial Number

90980823

Owner

Pillar Biosciences, Inc.

Attorney

Andrew T. Pettit

First Use Date

Mar 16, 2022

Filing Date

Feb 17, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ONCOREVEAL Trademark

Serial Number: 90980823 • Registration: 7347499

ONCOREVEAL is a trademark filed by Pillar Biosciences, Inc. on February 17, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Pillar Biosciences, Inc. (17 trademarks)

Natick, MA 01760

Entity Type: 03

Trademark Details

Filing Date

February 17, 2021

Registration Date

April 2, 2024

First Use Anywhere

March 16, 2022

First Use in Commerce

March 16, 2022

Published for Opposition

December 7, 2021

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 24, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 23, 2024 CNPR
DIVISIONAL PROCESSING COMPLETE
Feb 6, 2024 DPCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2024 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2024 TROA
DIVISIONAL REQUEST RECEIVED
Jan 30, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jan 30, 2024 ERTD
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 30, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 30, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 31, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 31, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 31, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2023 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 7, 2023 CHAN
ASSIGNED TO LIE
Jul 7, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 8, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 8, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 8, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 8, 2022 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 11, 2022 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Aug 10, 2022 SUPC
SOU EXTENSION 1 GRANTED
Aug 10, 2022 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 10, 2022 AITU
USE AMENDMENT FILED
Aug 1, 2022 IUAF
SOU EXTENSION 1 FILED
Aug 1, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 1, 2022 EEXT
TEAS STATEMENT OF USE RECEIVED
Aug 1, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 1, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 1, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 1, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 1, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 1, 2021 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 29, 2021 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 19, 2021 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 21, 2021 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Feb 23, 2021 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 23, 2021 PARI
NEW APPLICATION ENTERED
Feb 20, 2021 NWAP

Related Trademarks

More from this Owner

VERSATILE

VERSATILE

VERSATILE

VERSATILE

DECISION MEDICINE

DECISION MEDICINE

DECISION MEDICINE

DECISION MEDICINE

MRDTECT

MRDTECT

MRDTECT

MRDTECT